Remifentanil Sedation: A Five Year Retrospective Case Series Focusing on its Role in Non-Invasive Ventilation

Abstract

This is a retrospective observational study of practice in the intensive care unit (ICU) of a 700-bed district general hospital in the UK, which aims to describe the indications for remifentanil sedation in current critical care practice, with particular reference to its use in patients who are unable to tolerate non-invasive ventilation (NIV). Controlled drug records were analysed over a five year period and each prescription of remifentanil matched against patient records to determine the indication, dose and duration of use, alongside significant clinical events. Where patients received NIV, the duration of use and days of remifentanil sedation (if appropriate) were recorded. During the study period, a total of 3,259 patients were admitted to the ICU, of whom 469 (14.4%) received remifentanil. The majority of patients, n=286 (61.0%) received remifentanil while not intubated; for 232 (81.1%) it was prescribed to enable them to tolerate NIV. In this group, the mean duration of remifentanil infusion was 2.55 days, with the mean dose 4.55 mg/day, equivalent to approximately 0.04 μg/kg/min. Of the patients who were intubated, the most common indication was as part of a weaning strategy, the patients having previously been given longer acting agents. Due to its unique pharmacokinetic profile, remifentanil is used in a variety of specific clinical situations in our practice, in both intubated and non-intubated patients. In particular, we provide data to confirm its role as a safe and effective sedative in patients who are unable to tolerate NIV.

Keywords

remifentanil non-invasive ventilation conscious sedation

References

Egan

Lemmens

HJM

Fiset

. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79: 881–92.

Rozendaal

Spronk

Snellen

. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009;35: 291–98.

Breen

Karabinis

Malbrain

. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial. Crit Care 2005;9: R200–R210.

Muellejans

Matthey

Scholpp

Schill

. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care 2006;10: R91.

Constantin

J-M

Schneider

Cayot-Constantin

. Remifentanil-based sedation to treat noninvasive ventilation failure: a preliminary study. Intensive Care Med 2007;33: 82–87.

Rudner

Jalowiecki

Kawecki

. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy. Gastrointest Endosc 2003;57: 657–63.

Dunn

MJG

Mitchell

De Souza

Drummond

. Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department. Emerg Med J 2006;23: 57–58.

Brochard

Mancebo

Wysocky

. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333: 817–22.

Vitacca

Clini

Rubini

. Non-invasive mechanical ventilation in severe chronic obstructive lung disease and acute respiratory failure: short- and long-term prognosis. Intensive Care Med 1996;22: 94–100.

10.

Jeffrey

Warren

Flenley

. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: Risk factors and use of guidelines for management. Thorax 1992;47: 34–40.

11.

Ansermino

Brooks

Rosen

. Spontaneous ventilation with remifentanil in children. Paediatr Anaesth 2005;15: 115–21.

12.

Karabinis

Mandragos

Stergiopoulos

. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Crit Care 2004;8: R268–R280.